Home > Insider Trading > Filing (0001144204-19-005092)

Filing Details

Accession Number:: 0001144204-19-005092
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-05 17:26:49
Reporting Period:: 2019-02-01

Accepted Time:: 2019-02-05 17:26:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896264	Usana Health Sciences Inc	USNA	Medicinal Chemicals & Botanical Products (2833)	870500306

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1203301	W Myron Wentz	C/O Usana Health Sciences, Inc. 3838 West Parkway Blvd Salt Lake City UT 84120		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-02-01	8,662	$114.34	9,886,952	No	4	S	Indirect	Shares owned of record by Gull Global Limited
Common Stock	Disposition	2019-02-01	2,910	$115.57	9,884,042	No	4	S	Indirect	Shares owned of record by Gull Global Limited
Common Stock	Disposition	2019-02-01	8,354	$116.20	9,875,688	No	4	S	Indirect	Shares owned of record by Gull Global Limited
Common Stock	Disposition	2019-02-01	719	$116.97	9,874,969	No	4	S	Indirect	Shares owned of record by Gull Global Limited
Common Stock	Disposition	2019-02-04	1,400	$114.19	9,873,569	No	4	S	Indirect	Shares owned of record by Gull Global Limited
Common Stock	Disposition	2019-02-04	2,600	$115.32	9,870,969	No	4	S	Indirect	Shares owned of record by Gull Global Limited
Common Stock	Disposition	2019-02-04	4,555	$116.32	9,866,414	No	4	S	Indirect	Shares owned of record by Gull Global Limited
Common Stock	Disposition	2019-02-04	800	$116.90	9,865,614	No	4	S	Indirect	Shares owned of record by Gull Global Limited

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Shares owned of record by Gull Global Limited
No	4	S	Indirect	Shares owned of record by Gull Global Limited
No	4	S	Indirect	Shares owned of record by Gull Global Limited
No	4	S	Indirect	Shares owned of record by Gull Global Limited
No	4	S	Indirect	Shares owned of record by Gull Global Limited
No	4	S	Indirect	Shares owned of record by Gull Global Limited
No	4	S	Indirect	Shares owned of record by Gull Global Limited
No	4	S	Indirect	Shares owned of record by Gull Global Limited

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Weighted average price. Price range in multiple transactions was $113.94 to $114.93, inclusive.
The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.
Weighted average price. Price range in multiple transactions was $114.94 to $115.93, inclusive.
Weighted average price. Price range in multiple transactions was $115.94 to $116.80, inclusive.
Weighted average price. Price range in multiple transactions was $116.94 to $117.10, inclusive.
Weighted average price. Price range in multiple transactions was $113.70 to $114.68, inclusive.
Weighted average price. Price range in multiple transactions was $114.82 to $115.81, inclusive.
Weighted average price. Price range in multiple transactions was $115.82 to $116.76, inclusive.
Weighted average price. Price range in multiple transactions was $116.82 to $117.00, inclusive.
The total number of outstanding shares reflects 300 shares fewer than the total number of shares last reported as beneficially owned on a Form 4 filed on January 4, 2019, which 300 shares were sold on January 4, 2019, at an average weighted price of $115.00, with actual prices ranging from $114.71 to $115.67 (and were in addition to the sales reported on the Form 4 filed on January 4, 2019).